$16.86
0.72% yesterday
Nasdaq, Nov 25, 10:02 pm CET
ISIN
KYG011251066
Symbol
AFYA

Afya Target price 2024 - Analyst rating & recommendation

Afya Classifications & Recommendation:

Buy
38%
Hold
63%

Afya Price Target

Target Price $20.72
Price $16.86
Potential
Number of Estimates 8
8 Analysts have issued a price target Afya 2025 . The average Afya target price is $20.72. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 3 Analysts recommend Afya to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Afya stock has an average upside potential 2025 of . Most analysts recommend the Afya stock at Hold.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 575.77 568.13
27.67% 1.33%
EBITDA Margin 36.20% 42.28%
7.43% 16.81%
Net Margin 13.48% 20.41%
15.80% 51.44%

8 Analysts have issued a sales forecast Afya 2024 . The average Afya sales estimate is

$568m
Unlock
. This is
7.88% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$574m 6.89%
Unlock
, the lowest is
$557m 9.70%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $576m 27.67%
2024
$568m 1.33%
Unlock
2025
$645m 13.50%
Unlock
2026
$701m 8.70%
Unlock
2027
$768m 9.59%
Unlock

8 Analysts have issued an Afya EBITDA forecast 2024. The average Afya EBITDA estimate is

$240m
Unlock
. This is
1.14% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$250m 2.78%
Unlock
, the lowest is
$232m 4.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $208m 18.19%
2024
$240m 15.26%
Unlock
2025
$268m 11.78%
Unlock
2026
$292m 8.67%
Unlock
2027
$315m 7.88%
Unlock

EBITDA Margin

2023 36.20% 7.43%
2024
42.28% 16.81%
Unlock
2025
41.64% 1.51%
Unlock
2026
41.62% 0.05%
Unlock
2027
40.97% 1.56%
Unlock

4 Afya Analysts have issued a net profit forecast 2024. The average Afya net profit estimate is

$116m
Unlock
. This is
2.79% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$134m 18.61%
Unlock
, the lowest is
$108m 4.01%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $77.6m 7.50%
2024
$116m 49.40%
Unlock
2025
$143m 23.45%
Unlock
2026
$178m 24.43%
Unlock
2027
$270m 51.81%
Unlock

Net Margin

2023 13.48% 15.80%
2024
20.41% 51.44%
Unlock
2025
22.19% 8.72%
Unlock
2026
25.40% 14.47%
Unlock
2027
35.19% 38.54%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.86 1.28
7.50% 48.84%
P/E 13.12
EV/Sales 3.43

4 Analysts have issued a Afya forecast for earnings per share. The average Afya <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$1.28
Unlock
. This is
2.40% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.48 18.40%
Unlock
, the lowest is
$1.20 4.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $0.86 7.50%
2024
$1.28 48.84%
Unlock
2025
$1.59 24.22%
Unlock
2026
$1.97 23.90%
Unlock
2027
$3.00 52.28%
Unlock

P/E ratio

Current 13.45 48.74%
2024
13.12 2.45%
Unlock
2025
10.63 18.98%
Unlock
2026
8.54 19.66%
Unlock
2027
5.63 34.07%
Unlock

Based on analysts' sales estimates for 2024, the Afya stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.16 23.67%
2024
3.43 8.48%
Unlock
2025
3.02 11.90%
Unlock
2026
2.78 8.01%
Unlock
2027
2.54 8.75%
Unlock

P/S ratio

Current 2.47 27.09%
2024
2.68 8.56%
Unlock
2025
2.36 11.90%
Unlock
2026
2.17 8.01%
Unlock
2027
1.98 8.75%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today